Concepedia

Guillermo Villa

GV

27

Publications

1.1K

Citations

19

H-Index

1999

Active since

Affiliations

Amgen (Switzerland)(Current)

Amgen (United States)

University of Sheffield

Karolinska Institutet

Swedish Institute for Health Economics

Guillermo Villa is an author at Amgen (Switzerland) specializing in medicine, pharmacotherapy, and cardiovascular disease.

ORCID

Top concepts

Publications per year

1999–2023

27

Publications

27

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Gregg C. Fonarow, Anthony Keech, Terje R. Pedersen et al. · JAMA Cardiology · 2017 · 143 citations · Full text

Cost analysis of the Spanish renal replacement therapy programme

Guillermo Villa, Ana Rodríguez–Carmona, L Fernández-Ortiz et al. · Nephrology Dialysis Transplantation · 2011 · 87 citations · Full text

Cost‐Effectiveness of<scp>LDL</scp>‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

Guillermo Villa, Gregg C. Fonarow, Mickael Löthgren et al. · Clinical Cardiology · 2016 · 86 citations · Full text

Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease

Gregg C. Fonarow, Ben van Hout, Guillermo Villa et al. · JAMA Cardiology · 2019 · 83 citations · Full text

Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context

Peter P. Tóth, Mark D. Danese, Guillermo Villa et al. · Journal of Medical Economics · 2017 · 60 citations · Full text

Rows per page

1–5 of 27